A unique collection of xnum natural product monomers that meet the Lipinski's Rule of Five , a powerful tool for HTS and HCS screening;

A unique collection of xnum neurotransmitter receptor compounds, can be used for HTS and HCS screening；

A collection of xnum natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening.

A collection of xnum small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;

Diversity: Selected from 1,600,000 drug-like compounds, xnumcompounds representing 5000 scaffolds selected from a large drug-like chemical source；

A unique collection of xnum compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).

It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties, structure-diversity, etc.) were chosen. This library consists of xnum compounds without compro

A collection of xnum bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.

Diversity: Selected from 1,600,000 drug-like compounds covering rich chemical scaffolds, xnum compounds representing xnum scaffolds；

xnum macrocyclic compounds of known activity for high-throughput, high-content screening;

A unique collection of xnum covalent Inhibitors and other molecules with common warheads like chloroacetyl，2-Chloropropionyl，Acryloyl，sulfonyl fluoride, alkyne，acrylamide, ketocarbonyl，disulfide bond, etc.

A unique collection of xnum cancer cell differentiation inducing compounds for high throughput and high content screening;

A unique collection of xnum cytoskeleton-related compounds, can be used for HTS and HCS；

xnum drug fragments，a must-have tool for FBDD;

A unique collection of xnum compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study；

A unique collection of xnum fragment-like small molecules for FBDD;

Structurally diverse, medicinally active, and unique chemistry (strong IP potential);

A unique collection of xnum compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents；

Large quantity: contains 163,000 natural product derivatives and the number is continuously updating;

For your convenience, there are Diversity Sets of 5,000, 10,000, 15,000, and 20,000 compounds with no structure overlap.